Vagaonescu, T. D., Grines, C. L., Cox, D. A., Garcia, E., Tcheng, J. E., Griffin, J. J., … Stone, G. W. (2003). Does treatment with abciximab influence survival in patients with acute myocardial infarction and elevated baseline white blood cell count undergoing primary angioplasty? The CADILLAC trial. In AMERICAN JOURNAL OF CARDIOLOGY (Vol. 92, pp. 228L-228L). WASHINGTON, D.C.: EXCERPTA MEDICA INC.

Vagaonescu, T. D., C. L. Grines, D. A. Cox, E. Garcia, J. E. Tcheng, J. J. Griffin, G. Guagliumi, et al. “Does treatment with abciximab influence survival in patients with acute myocardial infarction and elevated baseline white blood cell count undergoing primary angioplasty? The CADILLAC trial.” In AMERICAN JOURNAL OF CARDIOLOGY, 92:228L-228L. EXCERPTA MEDICA INC, 2003.

Vagaonescu TD, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, et al. Does treatment with abciximab influence survival in patients with acute myocardial infarction and elevated baseline white blood cell count undergoing primary angioplasty? The CADILLAC trial. In: AMERICAN JOURNAL OF CARDIOLOGY. EXCERPTA MEDICA INC; 2003. p. 228L-228L.

Vagaonescu, T. D., et al. “Does treatment with abciximab influence survival in patients with acute myocardial infarction and elevated baseline white blood cell count undergoing primary angioplasty? The CADILLAC trial.” AMERICAN JOURNAL OF CARDIOLOGY, vol. 92, no. 6A, EXCERPTA MEDICA INC, 2003, pp. 228L-228L.

Vagaonescu TD, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Fahy M, Costantini C, Mehran R, Stone GW. Does treatment with abciximab influence survival in patients with acute myocardial infarction and elevated baseline white blood cell count undergoing primary angioplasty? The CADILLAC trial. AMERICAN JOURNAL OF CARDIOLOGY. EXCERPTA MEDICA INC; 2003. p. 228L-228L.